Posts by Jodi Gilman, PhD
Cannabis Use Disorder Can Develop Soon After a Medical Marijuana Card Is Obtained
In a clinical trial at Massachusetts General Hospital, patients who obtained a medical marijuana card for pain, anxiety, or depression had almost three times higher risk of cannabis use disorder than those whose card was delayed, and they had no major improvement in symptoms—but cannabis helped patients with insomnia.
Portable Imaging Test Shows Promise for Detection of Cannabis Intoxication
Data from a double-blind, placebo-controlled crossover study suggest that activation of the prefrontal cortex, detectable by a noninvasive, portable form of imaging, is a biomarker of cannabis intoxication.
Translation, Discovery and Collaboration in Psychiatry
Researchers from the Department of Psychiatry at Massachusetts General Hospital discuss their collaborative work in clinical and translational research.
Marijuana and the Young Brain
Jodi Gilman, PhD, director of neuroscience at the Center for Addiction Medicine, discusses what her research has shown on the effects of marijuana in the teen brain and how those effects are dependent on the age at which a young person begins to use.
fNIRS Brain Imaging Detects Changes to Brain Function After Cannabis Use
To examine how cannabis use affects the brain, most studies use positron emission tomography, which exposes subjects to radiation. Mass General researchers examined whether functional near-infrared spectroscopy is a feasible alternative for such research.
Jodi Gilman, PhD, received her BS from Tufts University in 2004. She received her PhD in neuroscience from Brown University in 2008, where she used neuroimaging techniques to study the acute and long-term functional and structural effects of alcohol on brain regions involved in motivation and emotion. She came to the Center for Addiction Medicine at Mass General in 2013 to study the effects of cannabis on the brains of young adult users. She is the recipient of the Norman Zinberg Fellowship in Addiction Psychiatry from Harvard Medical School, as well as a Career Development Award from the National Institute on Drug Abuse entitled “Neurobehavioral Characterization of Social Influence in Drug Addiction.” Dr. Gilman’s work has been features in media outlets throughout the world, including Reuter’s, NPR’s Science Friday broadcast and the BBC.